Physician profile
Timothy S Johnston
NPI 1528097847
$510.66
in general payments reported to CMS, 2019-2025
12 companies · $67.76 in 2025
The $67.76 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2021: $99.39 · 2023: $42.31 · 2024: $43.83 · 2025: $67.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $106.64 | 2019 | |
| Novo Nordisk INC | $85.53 | 2021-2023 | Wegovy |
| Endogastric Solutions, INC | $52.87 | 2019 | |
| Hologic Sales and Service, LLC | $50.86 | 2024-2025 | Thinprep 2000 Processor, Aptima |
| Pfizer INC. | $48.41 | 2019-2024 | |
| Sunovion Pharmaceuticals INC. | $40.80 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $30.87 | 2021-2025 | Capvaxive, M-M-R II |
| Acadia Pharmaceuticals INC | $29.12 | 2025 | Daybue |
| Ultragenyx Pharmaceutical INC. | $23.67 | 2023 | |
| Genentech USA, INC. | $17.25 | 2019 | |
| Sanofi Pasteur INC. | $12.35 | 2019 | |
| Astellas Pharma US INC | $12.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.